Predictors of Post-COVID Clinical and Cognitive Consequences
新冠疫情后临床和认知后果的预测因素
基本信息
- 批准号:10589434
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAllelesAlzheimer&aposs disease patientApolipoprotein EAreaBlood Coagulation DisordersCOVID-19COVID-19 complicationsCOVID-19 cytokine stormCOVID-19 impactCOVID-19 severityCOVID-19 survivorsChronicClinicalCognitiveCognitive deficitsComplexCoughingDataDevelopmentDiagnosticDiseaseDyspneaEncephalopathiesFatigueFunctional disorderFutureGenesGoalsHeadacheHealthHealthcareHourHypoxiaImpaired cognitionImpairmentIncidenceInfectionInflammationInterleukin-6KnowledgeLinkLong COVIDLong-Term EffectsMemory impairmentMental HealthNeurocognitiveNeurocognitive DeficitNeurologicNeutrophiliaObservational StudyObstructive Sleep ApneaPathway interactionsPatientsPilot ProjectsPost-Acute Sequelae of SARS-CoV-2 InfectionQuality of lifeRecoveryRecovery of FunctionRehabilitation therapyReportingResearchRespiratory Signs and SymptomsRiskSARS-CoV-2 infectionSeveritiesSleepSleep Apnea SyndromesSleep DeprivationSleep FragmentationsSleep disturbancesSymptomsTNF geneTestingTherapeuticVeteransVirusVisitacute infectionbrain fogcognitive functioncoronavirus diseasecytokinedisabilityimprovedinflammatory markernovelphysical conditioningphysical symptompoor sleeppost SARS-CoV-2 infectionpost-COVID-19prospectiveresearch studyrespiratoryresponsesevere COVID-19sleep qualitytherapeutic targettrait
项目摘要
Patients recovering from acute COVID-19 infection often suffer from a multitude of debilitating chronic physical
symptoms that can last up to 6 months or more. The incidence of fatigue, cognitive impairment and respiratory
symptoms are reported to be very high in the post-COVID period. The underlying pathophysiology of cognitive
impairment is unclear in these patients. Notably, sleep disturbances are common during this post-COVID
period, and sleep apnea has been associated with an increased risk for severe COVID infection. Thus, it is
conceivable that sleep fragmentation, per se, may confer an increased risk for chronic cognitive deficits in
Veterans post-COVID. Our proposed pilot project will determine if there is a link between post-COVID sleep
disturbances, sleep apnea and cognitive function. Knowledge gained from our examinations may guide
development of novel management pathways, i.e., mitigation of sleep disturbances may present a therapeutic
strategy for alleviating chronic post-COVID cognitive impairment.
Aim1 will investigate the effect of sleep duration and sleep quality on neurocognitive function in post-COVID
Veterans. Aim 2 will study whether the severity of OSA determines neurocognitive function Veterans who are
post-COVID. This is an observational study where we will gather retrospective as well as prospective data on
the long-term effects of COVID on neurocognitive function and sleep. Our long-term goal is to enhance
rehabilitation and recovery of function of Veterans suffering from post-COVID consequences that may arise
due to sleep disturbances, with the ultimate objective of improving the overall health and quality of life of
Veterans recovering from COVID-19 infection.
从急性 COVID-19 感染中恢复的患者通常会遭受多种慢性身体疾病的困扰
症状可持续长达 6 个月或更长时间。疲劳、认知障碍和呼吸障碍的发生率
据报道,新冠肺炎后时期的症状非常严重。认知的潜在病理生理学
这些患者的损伤尚不清楚。值得注意的是,睡眠障碍在新冠疫情之后很常见
睡眠呼吸暂停与严重新冠病毒感染的风险增加有关。因此,它是
可以想象,睡眠碎片化本身可能会增加慢性认知缺陷的风险
新冠疫情后的退伍军人。我们提议的试点项目将确定新冠疫情后睡眠之间是否存在联系
干扰、睡眠呼吸暂停和认知功能。从我们的考试中获得的知识可以指导
开发新的管理途径,即减轻睡眠障碍可能是一种治疗方法
缓解新冠肺炎后慢性认知障碍的策略。
Aim1 将研究新冠疫情后睡眠时间和睡眠质量对神经认知功能的影响
退伍军人。目标 2 将研究 OSA 的严重程度是否决定神经认知功能
新冠疫情后。这是一项观察性研究,我们将收集回顾性和前瞻性数据
新冠病毒对神经认知功能和睡眠的长期影响。我们的长期目标是增强
遭受新冠疫情后可能出现的后果的退伍军人的康复和功能恢复
由于睡眠障碍,最终目标是改善整体健康和生活质量
从 COVID-19 感染中康复的退伍军人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susmita Chowdhuri其他文献
Susmita Chowdhuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susmita Chowdhuri', 18)}}的其他基金
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans with Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
气道正压通气治疗对患有慢性阻塞性肺疾病和共病阻塞性睡眠呼吸暂停(重叠综合征)的老年退伍军人临床结果的影响
- 批准号:
10356081 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans with Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
气道正压通气治疗对患有慢性阻塞性肺疾病和共病阻塞性睡眠呼吸暂停(重叠综合征)的老年退伍军人临床结果的影响
- 批准号:
10599838 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Targeting Chemoreceptor Control of Breathing during Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
针对睡眠期间呼吸的化学感受器控制,以减轻阿片类药物相关的睡眠呼吸障碍
- 批准号:
10295173 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Targeting Chemoreceptor Control of Breathing during Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
针对睡眠期间呼吸的化学感受器控制,以减轻阿片类药物相关的睡眠呼吸障碍
- 批准号:
10041688 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Targeting Chemoreceptor Control of Breathing during Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
针对睡眠期间呼吸的化学感受器控制,以减轻阿片类药物相关的睡眠呼吸障碍
- 批准号:
10578662 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Impact of Sleep Apnea in Elderly Veterans with Comorbid COPD
睡眠呼吸暂停对患有慢性阻塞性肺病的老年退伍军人的影响
- 批准号:
9143237 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly
老年人睡眠呼吸暂停的病理生理学引导治疗
- 批准号:
9105161 - 财政年份:2015
- 资助金额:
-- - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Augmenting Pharmacogenetics with Multi-Omics Data and Techniques to Predict Adverse Drug Reactions to NSAIDs
利用多组学数据和技术增强药物遗传学,预测 NSAID 的药物不良反应
- 批准号:
10748642 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identifying new regulators of cardiac fibrosis and inflammation using zebrafish
使用斑马鱼识别心脏纤维化和炎症的新调节因子
- 批准号:
10892436 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Enhancing TET activity for the treatment of hematological malignancy
增强 TET 活性治疗血液恶性肿瘤
- 批准号:
10717715 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The effects of APOE genotype in homeostatic microglial function in preclinical APOE mouse model
APOE基因型对临床前APOE小鼠模型稳态小胶质细胞功能的影响
- 批准号:
10828613 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Single-Cell RNA Sequencing of Cardiac Organoids to Determine the Genetic Basis for Cell-Specific Responses to Anticancer Drugs
心脏类器官的单细胞 RNA 测序以确定抗癌药物细胞特异性反应的遗传基础
- 批准号:
10679493 - 财政年份:2023
- 资助金额:
-- - 项目类别: